Nuclear receptors and their role in Epstein - Barr virus induced B cell transformation

Experimental Oncology

Volumn 31, Issue 2, 2009, Pages 67-73

  Yenamandra, S P ^a   Klein, G ^a   Kashuba, E ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

Author keywords

Cell transformation; EBNA; EBV; Expression profiling; Microarray; Nuclear receptor

Indexed keywords

CELL NUCLEUS RECEPTOR; EPSTEIN BARR VIRUS ANTIGEN; LATENT MEMBRANE PROTEIN 1; CELL RECEPTOR;

ANTIGEN EXPRESSION; B LYMPHOCYTE; CELL IMMORTALIZATION; EPSTEIN BARR VIRUS; HUMAN; LATENT VIRUS INFECTION; LYMPHOCYTE TRANSFORMATION; MALIGNANT TRANSFORMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; REVIEW; VIRUS CELL TRANSFORMATION; VIRUS INFECTION; VIRUS LATENCY; ANIMAL; CELL TRANSFORMATION; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; VIROLOGY;

ANIMALS; B-LYMPHOCYTES; CELL TRANSFORMATION, NEOPLASTIC; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 68849091002     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Kieff E, Rikinson A. Epstein - Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM, et al, eds. Fields Virology. Philadelphia: Lippincott Williams&Wilkins, 2001: 2511-2574
2. Rikinson A, Kieff E. Epstein - Barr virus. In: Fields BN, Knipe DM, Howley PM, et al, eds. Fields Virology. Philadelphia: Lippincott Williams&Wilkins, 2001: 2575-2628
3. Hopwood PA, Brooks L, Parratt R, et al. Persistent epstein - Barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients. Transplantation 2002; 74: 194-202. (Pubitemid 34810286)
4. Joseph AM, Babcock GJ, Thorley-Lawson DA. Cells expressing the Epstein - Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils. J Virol 2000; 74: 9964-9971
5. Joseph AM, Babcock GJ, Thorley-Lawson DA. EBV persistence involves strict selection of latently infected B cells. J Immunol 2000; 165: 2975-2981
6. Klein G. Perspectives in studies of human tumor viruses. Front Biosci 2002; 7: d268-74.
7. Tomkinson B, Robertson E, Kieff E. Epstein - Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol 1993; 67: 2014-2025 (Pubitemid 23088375)
8. Kaiser C, Laux G, Eick D, et al. The proto-oncogene c-myc is a direct target gene of Epstein - Barr virus nuclear antigen 2. J Virol 1999; 73: 4481-4484 (Pubitemid 29189900)
9. Bornkamm GW, Hammerschmidt W. Molecular virology of Epstein - Barr virus. Philos Trans R Soc Lond B Biol Sci 2001; 356: 37-59. (Pubitemid 32442745)
10. Yenamandra SP, Lundin A, Arulampalam V, et al. Expression profile of nuclear receptors upon Epstein - Barr virus induced B-cell transformation. Exp Oncol 2009; 31: 92-96
11. You LR, Lin FJ, Lee CT, et al. Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 2005; 435: 98-104.
12. You LR, Takamoto N, Yu CT, et al. Mouse lacking COUP-TFII as an animal model of Bochdalek-type congenital diaphragmatic hernia. Proc Natl Acad Sci USA 2005; 102: 16351-16356 (Pubitemid 41688917)
13. Winoto A, and Littman DR. Nuclear hormone receptors in T lymphocytes. Cell 2002; 109 Suppl: S57-66.
14. He YW. Orphan nuclear receptors in T lymphocyte development. J Leukoc Biol 2002; 72: 440-446
15. Li QX, Ke N, Sundaram R, et al. NR4A1, 2, 3 - an orphan nuclear hormone receptor family involved in cell apoptosis and carcinogenesis. Histol Histopathol 2006; 21: 33-40.
16. Zechel C. The germ cell nuclear factor (GCNF). Mol Reprod Dev 2005; 72: 550-556 (Pubitemid 41511047)
17. Gu P, LeMenuet D, Chung AC, et al. Orphan nuclear receptor GCNF is required for the repression of pluripotency genes during retinoic acid-induced embryonic stem cell differentiation. Mol Cell Biol 2005; 25: 8507-8519 (Pubitemid 41369172)
18. Chung AC, Xu X, Niederreither KA, et al. Cooney, Loss of orphan nuclear receptor GCNF function disrupts forebrain development and the establishment of the isthmic organizer. Dev Biol 2006; 293: 13-24.
19. Sato N, Kondo M, Arai K. The orphan nuclear receptor GCNF recruits DNA methyltransferase for Oct-3/4 silencing. Biochem Biophys Res Commun 2006; 344: 845-851
20. Mattson JC. Acute promyelocytic leukemia. From morphology to molecular lesions. Clin Lab Med 2000; 20: 83-103.
21. Cariati R, Zancai P, Quaia M, et al. Retinoic acid induces persistent, RARalpha-mediated anti-proliferative responses in Epstein-Barr virus-immortalized b lymphoblasts carrying an activated C-MYC oncogene but not in Burkitt's lymphoma cell lines. Int J Cancer 2000; 86: 375-384 (Pubitemid 30187499)
22. Sista ND, Pagano JS, Liao W, et al. Retinoic acid is a negative regulator of the Epstein - Barr virus protein (BZLF1) that mediates disruption of latent infection. PROC NATL ACAD SCI USA 1993; 90: 3894-3898
23. Sista ND, Barry C, Sampson K, et al. Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR alpha and RXR alpha. Nucleic Acids Res 1995; 23: 1729-1736
24. Lomo J, Smeland EB, Ulven S, et al. RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes. J Cell Physiol 1998; 175: 68-77.
25. Laganiere J, Deblois G, Giguere V. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells. Mol Endocrinol 2005; 19: 1584-1592 (Pubitemid 41002987)
26. Rasooly R, Schuster GU, Gregg JP, et al. Retinoid x receptor agonists increase bcl2a1 expression and decrease apoptosis of naive T lymphocytes. J Immunol 2005; 175: 7916-7929 (Pubitemid 41798352)
27. Pegman PM, Smith SM, D'Souza BN, et al. Epstein - Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ κ-dependent pathway. J Virol 2006; 80: 8133-8144
28. Pascual G, Fong AL, Ogawa S, et al. A SUMOylationdependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 2005; 437: 759-763 (Pubitemid 41486547)
29. Kelly D, Campbell JI, King TP, et al. G Grant, EA Jansson, AG Coutts, S Pettersson, and S Conway, Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 2004; 5: 104-112
30. Jones DC, Ding X, Daynes RA. Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent. J Biol Chem 2002; 277: 6838-6845
31. Schlezinger JJ, Jensen BA, Mann KK, et al. Peroxisome proliferator-activated receptor gamma-mediated NF-κB activation and apoptosis in pre-B cells. J Immunol 2002; 169: 6831-6841 (Pubitemid 36899268)
32. Konopleva M, Elstner E, McQueen TJ, et al. Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. Mol Cancer Ther 2004; 3: 1249-1262 (Pubitemid 39440170)
33. Ray DM, Akbiyik F, Bernstein SH, et al. CD40 engagement prevents peroxisome proliferator-activated receptor gamma agonist-induced apoptosis of B lymphocytes and B lymphoma cells by an NF-kappa B-dependent mechanism. J Immunol 2005; 174: 4060-4069 (Pubitemid 40395982)
34. Fajas L, Egler V, Reiter R, et al. PPARgamma controls cell proliferation and apoptosis in an RB-dependent manner. Oncogene 2003; 22: 4186-4193 (Pubitemid 36876239)
35. Welch JS, Ricote M, Akiyama TE, et al. PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc Natl Acad Sci USA 2003; 100: 6712-6717 (Pubitemid 36666645)
36. Suzawa M, Takada I, Yanagisawa J, et al. Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade. Nat Cell Biol 2003; 5: 24-30.
37. Issa JP, Ottaviano YL, Celano P, et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7: 536-540 (Pubitemid 24308343)
38. Ohtake F, Takeyama K, Matsumoto T, et al. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 2003; 423: 545-550 (Pubitemid 36648579)
39. Phiel KL, Henderson RA, Adelman SJ, et al. Elloso, Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol Lett 2005; 97: 107-113
40. Erlandsson MC, Jonsson C.A, Islander U, et al. Oestrogen receptor specificity in oestradiol-mediated effects on B lymphopoiesis and immunoglobulin production in male mice. Immunology 2003; 108: 46-51.
41. Islander U, Erlandsson MC, Hasseus B, et al. Influence of oestrogen receptor alpha and β on the immune system in aged female mice. Immunology 2003; 110: 149-157 (Pubitemid 37059683)
42. Yang SH, Liu R, Perez EJ, et al. Mitochondrial localization of estrogen receptor β. Proc Natl Acad Sci USA 2004; 101: 4130-4135
43. Li J, McMurray RW. Effects of estrogen receptor subtype-selective agonists on immune functions in ovariectomized mice. Int Immunopharmacol 2006; 6: 1413-1423 (Pubitemid 44038682)
44. Shim GJ, Wang L, Andersson S, et al. Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc Natl Acad Sci USA 2003; 100: 6694-6699 (Pubitemid 36675339)
45. Willy PJ, Umesono K, Ong ES, et al. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 1995; 9: 1033-1045
46. Joseph SB, Castrillo A, Laffitte BA, et al. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 2003; 9: 213-219 (Pubitemid 36227724)
47. Joseph SB, Bradley MN, Castrillo A, et al. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 2004; 119: 299-309. (Pubitemid 39360910)
48. Kuppers R, Klein U, Schwering I, et al. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest 2003; 111: 529-537 (Pubitemid 36228010)
49. Grayson J, Dooley NJ, Koski IR, et al. Immunoglobulin production induced in vitro by glucocorticoid hormones: T cell-dependent stimulation of immunoglobulin production without B cell proliferation in cultures of human peripheral blood lymphocytes. J Clin Invest 1981; 68: 1539-1547 (Pubitemid 12194410)
50. Emilie D, Karray B, Crevon MC, et al. B cell differentiation and interleukin 2 (IL2): corticosteroids interact with monocytes to enhance the effect of IL2. Eur J Immunol 1987; 17: 791-795 (Pubitemid 17101868)
51. Tomita M, Chrousos GP, Brandon DD, et al. Glucocorticoid receptors in Epstein - Barr virus-transformed human lymphocytes. Horm Metab Res 1985; 17: 674-678 (Pubitemid 16176922)
52. Andreau K, Lemaire C, Souvannavong V, et al. Induction of apoptosis by dexamethasone in the B cell lineage. Immunopharmacology 1998; 40: 67-76. (Pubitemid 28434955)
53. Jabara HH, Brodeur SR, Geha RS. Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching. J Clin Invest 2001; 107: 371-378
54. Quaia M, Zancai P, Cariati R, et al. Glucocorticoids promote the proliferation and antagonize the retinoic acid-mediated growth suppression of Epstein-Barr virus-immortalized B lymphocytes. Blood 2000; 96: 711-718 (Pubitemid 30463396)
55. Geng CD, Vedeckis WV. c-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter. J Biol Chem 2005; 280: 43264-43271
56. Brewer JA, Khor B, Vogt SK, et al. T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation. Nat Med 2003; 9: 1318-1322 (Pubitemid 37279857)
57. Tronche F, Opherk C, Moriggl R, et al. Glucocorticoid receptor function in hepatocytes is essential to promote post-natal body growth. Genes Dev 2004; 18: 492-497 (Pubitemid 38372806)
58. Nakai A, Kartha S, Sakurai A, et al. A human early response gene homologous to murine nur77 and rat NGFI-B, and related to the nuclear receptor superfamily. Mol Endocrinol 1990; 4: 1438-1443 (Pubitemid 20356603)
59. Pei L, Castrillo A, and Tontonoz P. Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77. Mol Endocrinol 2006; 20: 786-794
60. Pei L, Castrillo A, Chen M, et al. Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. J Biol Chem 2005; 280: 29256-29262 (Pubitemid 41161379)
61. Li H, Kolluri SK, Gu J, et al. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 2000; 289: 1159-1164 (Pubitemid 30650723)
62. Lin B, Kolluri SK, Lin F, et al. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 2004; 116: 527-540 (Pubitemid 38264430)
63. Suzuki S, Suzuki N, Mirtsos C, et al. Nur77 as a survival factor in tumor necrosis factor signaling. Proc Natl Acad Sci USA 2003; 100: 8276-8280 (Pubitemid 36842535)
64. Hong CY, Park JH, Ahn RS, et al. Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor alpha. Mol Cell Biol 2004; 24: 2593-2604
65. Mapara MY, Weinmann P, Bommert K, et al. Involvement of NAK-1, the human nur77 homologue, in surface IgM-mediated apoptosis in Burkitt lymphoma cell line BL41. Eur J Immunol 1995; 25: 2506-2510
66. Lee JM, Lee KH, Weidner M, et al. Epstein - Barr virus EBNA2 blocks Nur77-mediated apoptosis. Proc Natl Acad Sci USA 2002; 99: 11878-11883 (Pubitemid 34994492)
67. Lee JM, Lee KH, Farrell CJ, et al. EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli. J Virol 2004; 78: 12694-12697
68. Kurebayashi S, Ueda E, Sakaue M, et al. Retinoid-related orphan receptor gamma (RORgamma) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis. Proc Natl Acad Sci USA 2000; 97: 10132-10137 (Pubitemid 30680867)
69. Eberl G, Marmon S, Sunshine MJ, et al. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 2004; 5: 64-73. (Pubitemid 38081470)
70. Sun Z, Unutmaz D, Zou YR, et al. Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science 2000; 288: 2369-2373 (Pubitemid 30448162)
71. Yu VC, Delsert C, Andersen B, et al. RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 1991; 67: 1251-1266 (Pubitemid 121001537)
72. Hallenbeck PL, Marks MS, Lippoldt E, et al. Heterodimerization of thyroid hormone (TH) receptor with H-2RIIBP (RXR beta) enhances DNA binding and TH-dependent transcriptional activation. Proc Natl Acad Sci USA1992; 89: 5572-5576
73. Sugawara A, Uruno A, Nagata T, et al. Characterization of mouse retinoid X receptor (RXR)-beta gene promoter: negative regulation by tumor necrosis factor (TNF)-alpha. Endocrinology 1998; 139: 3030-3033 (Pubitemid 28512419)
74. Forrest D, Erway LC, Ng L, et al. Thyroid hormone receptor beta is essential for development of auditory function. Nat Genet 1996; 13: 354-357 (Pubitemid 26230504)
75. Forrest D, Hanebuth E, Smeyne RJ, et al. Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor beta: evidence for tissue-specific modulation of receptor function. Embo J 1996; 15: 3006-3015 (Pubitemid 26187749)
76. Jurutka PW, Remus LS, Whitfield GK, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 2000; 14: 401-420
77. Morgan JW, Reddy GS, Uskokovic MR, et al. Functional block for 1 alpha,25-dihydroxyvitamin D3-mediated gene regulation in human B lymphocytes. J Biol Chem 1994; 269: 13437-13443 (Pubitemid 2078436) (Pubitemid 24206117)
78. Elstner E, Lee YY, Hashiya M, et al. 1 alpha,25-Dihydroxy- 20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro. Blood 1994; 84: 1960-1967 (Pubitemid 24286148) (Pubitemid 2142767)
79. Gombart AF, Luong QT, and Koeffler HP. Vitamin D compounds: activity against microbes and cancer. Anticancer Res 2006; 26: 2531-2542 (Pubitemid 44155532)
80. Norman AW. Vitamin D Receptor (VDR): New assignments for an already busy receptor. Endocrinology 2006; 147: 5542-5548
81. Kashuba EV, Gradin K, Isaguliants M, et al. Regulation of transactivation function of the aryl hydrocarbon receptor by the Epstein - Barr virus-encoded EBNA-3 protein. J Biol Chem 2006; 281: 1215-1223